30 Day Survival Rates Following Congenital Heart Disease Surgery and Interventional Procedures


The National Congenital Heart Disease Audit (NCHDA) has today published the 2010/13 annual analysis. The analysis covers 22,979 congenital heart operations and transcatheter interventional procedures undertaken across 34 UK centres, including all 14 specialist paediatric units, between 2010 and 2013. Key findings include:

  • Survival at 30-days after each of the 56 surgical and transcatheter cardiovascular interventions most frequently undertaken to treat congenital heart disease in children, young people and adults continues to be within the appropriate limits and not below the red alert limit.
  • For the 56 specific procedures used as a basis of inter‐unit comparison, there was one warning level outliers for paediatric cardiac surgery at a single centre and none for paediatric intervention, adult congenital heart disease (ACHD) surgery and ACHD intervention. The hospital concerned has been contacted by NICOR and the relevant professional societies, and the centre’s response is available on the NCHDA portal.
  • Analysis of the 30 day post procedural outcomes for all hospitals shows an upward trend in survival in the most recent 18 months. The overall 30 day survival for all congenital heart disease procedures is extremely high and indeed one of the highest reported anywhere in the world.
  • Antenatal diagnosis of congenital heart disease has gradually improved over the past 8 years. In 2013/14, approaching 45% of infants who required a procedure to treat a congenital heart malformation in the first year of life were diagnosed through antenatal screening, compared to less than a quarter of cases in 2003/4.